Covered recipient · General Payments record
STEVEN J VACEK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,001.90
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.70 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $97.05 | 4 |
| Novo Nordisk AS | $80.19 | 5 |
| Lilly USA, LLC | $48.28 | 3 |
| Amgen Inc. | $41.14 | 2 |
| DEXCOM, INC. | $38.07 | 2 |
| Abbott Laboratories | $36.50 | 2 |
| Lundbeck LLC | $25.16 | 1 |
| IBSA Pharma Inc. | $24.56 | 1 |
| Supernus Pharmaceuticals, Inc. | $23.71 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.11 | 1 |
| GlaxoSmithKline, LLC. | $14.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876608 | CMS |
| Abbott Laboratories | $13.98 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876610 | CMS |
| ABBVIE INC. | $34.22 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106263328 | CMS |
| ABBVIE INC. | $19.15 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106263330 | CMS |
| ABBVIE INC. | $19.66 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106263332 | CMS |
| ABBVIE INC. | $24.02 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106263334 | CMS |
| Amgen Inc. | $20.24 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116189441 | CMS |
| Amgen Inc. | $20.90 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116189436 | CMS |
| Dexcom, Inc. | $20.14 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153338689 | CMS |
| Dexcom, Inc. | $17.93 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153338691 | CMS |
| GlaxoSmithKline, LLC. | $14.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116702017 | CMS |
| IBSA Pharma Inc. | $24.56 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974319 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.11 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146774104 | CMS |
| Lilly USA, LLC | $13.41 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135434125 | CMS |
| Lilly USA, LLC | $17.77 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135391843 | CMS |
| Lilly USA, LLC | $17.10 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135350856 | CMS |
| Lundbeck LLC | $25.16 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145977345 | CMS |
| Novo Nordisk Inc | $13.21 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097638256 | CMS |
| Novo Nordisk Inc | $14.52 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097231103 | CMS |
| Novo Nordisk Inc | $21.30 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096784569 | CMS |
| Novo Nordisk Inc | $17.90 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096861066 | CMS |
| Novo Nordisk Inc | $13.26 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097813449 | CMS |
| Supernus Pharmaceuticals, Inc. | $23.71 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147839811 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.